People living with inflammatory bowel disease (IBD) have new hope, with clinical trials beginning for a breakthrough treatment for one of the most ...
The findings from the PROSPERO study reveal that multiple hospitalizations, long-term disease duration, prior surgeries, and factors like corticosteroid use and total parenteral nutrition ...
WHETHER we’re aiming for better sleep or clearer skin, there’s a supplement for just about everything these days. But do we ...
A doctor and medical advisor has shared the top five factors that could increase people's risk at getting colorectal cancer, ...
D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...
A colorectal surgeon named Dr Cedrek McFadden has shared the top five reasons why people may be at risk of getting colorectal ...
San Francisco, California Wednesday, February 5, 2025, 16:00 Hrs [IST] ...
AbbVie (NYSE:ABBV – Get Free Report) had its price objective lifted by equities research analysts at BMO Capital Markets from ...
Teva Pharma Industries Ltd ADR, Allergan PLC, Johnson & Johnson, CVS Health Corp. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com ...
Over 200 million Americans are covered by private health insurance, yet one in seven claims for treatment are denied. The ...
AbbVie (NYSE:ABBV – Get Free Report) had its price target upped by stock analysts at Guggenheim from $212.00 to $214.00 in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback